{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:33:58Z","timestamp":1793504038796,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T00:00:00Z","timestamp":1751155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine Reports"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.pmedr.2025.103161","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:44:52Z","timestamp":1751427892000},"page":"103161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Health-related behavioral changes following the use of psychedelics in naturalistic settings"],"prefix":"10.1016","volume":"56","author":[{"given":"Pedro J.","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Penn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saundra","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlen C.","family":"Moller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Raison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmedr.2025.103161_bb0005","series-title":"Major life changes following psychedelic use: A retrospective survey among people using psychedelics naturalistically [Preprint]","author":"Aday","year":"2024"},{"issue":"1","key":"10.1016\/j.pmedr.2025.103161_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-024-06722-6","article-title":"Practical considerations in the establishment of psychedelic research programs","volume":"242","author":"Barnett","year":"2025","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.pmedr.2025.103161_bb0015","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.pmedr.2025.103161_bb0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/02698811211008567","article-title":"Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?","volume":"36","author":"Carhart-Harris","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.pmedr.2025.103161_bb0025","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881119845793","article-title":"Cessation and reduction in alcohol consumption and misuse after psychedelic use","volume":"33","author":"Garcia-Romeu","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pmedr.2025.103161_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0269881117735685","article-title":"The relationships of classic psychedelic use with criminal behavior in the United States adult population","volume":"32","author":"Hendricks","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pmedr.2025.103161_bb0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.pmedr.2025.103161_bb0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/02698811211058933","article-title":"Psilocybin use is associated with lowered odds of crime arrests in US adults: a replication and extension","volume":"36","author":"Jones","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pmedr.2025.103161_bb0045","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1038\/s41598-022-06580-2","article-title":"Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study","volume":"12","author":"Jones","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.pmedr.2025.103161_bb0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/02791072.2022.2077155","article-title":"Ayahuasca and public health II: health tatus in a large sample of Ayahuasca-ceremony participants in the Netherlands","volume":"55","author":"Kohek","year":"2023","journal-title":"J. Psychoactive Drugs"},{"issue":"7","key":"10.1016\/j.pmedr.2025.103161_bb0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/02698811231158245","article-title":"Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: findings from the global drug survey 2020","volume":"37","author":"Kopra","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pmedr.2025.103161_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2024.117134","article-title":"Psychedelic public health: state of the field and implications for equity","volume":"357","author":"Kuiper","year":"2024","journal-title":"Soc. Sci. Med."},{"issue":"6","key":"10.1016\/j.pmedr.2025.103161_bb0065","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.biopsych.2023.03.013","article-title":"Acute mood-elevating properties of microdosed lysergic acid diethylamide in healthy volunteers: a home-administered randomized controlled trial","volume":"94","author":"Murphy","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pmedr.2025.103161_bb0070","article-title":"Behavioral psychedelics: integrating mind and behavior to improve health and resilience","volume":"13","author":"Neuhaus","year":"2022","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.pmedr.2025.103161_bb0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/02791072.2019.1567961","article-title":"Ayahuasca and public health: health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users","volume":"51","author":"Ona","year":"2019","journal-title":"J. Psychoactive Drugs"},{"issue":"5","key":"10.1016\/j.pmedr.2025.103161_bb0080","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/0269881117691453","article-title":"The association of psychedelic use and opioid use disorders among illicit users in the United States","volume":"31","author":"Pisano","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pmedr.2025.103161_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104706","article-title":"The emerging science of microdosing: a systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field","volume":"139","author":"Polito","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pmedr.2025.103161_bb0090","article-title":"Effects of naturalistic psychedelic use on depression, anxiety, and well-being: associations with patterns of use, reported harms, and transformative mental states","volume":"13","author":"Raison","year":"2022","journal-title":"Front. Psychol."},{"issue":"1","key":"10.1016\/j.pmedr.2025.103161_bb0095","doi-asserted-by":"crossref","first-page":"14427","DOI":"10.1038\/s41598-021-93787-4","article-title":"Associations between lifetime classic psychedelic use and cardiometabolic diseases","volume":"11","author":"Simonsson","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pmedr.2025.103161_bb0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/02698811211008554","article-title":"Psychedelics and health behaviour change","volume":"36","author":"Teixeira","year":"2022","journal-title":"J. Psychopharmacol."}],"updated-by":[{"DOI":"10.1016\/j.pmedr.2026.103574","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000}},{"DOI":"10.1016\/j.pmedr.2026.103574","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Preventive Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335525002001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335525002001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:10:45Z","timestamp":1752765045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211335525002001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":20,"alternative-id":["S2211335525002001"],"URL":"https:\/\/doi.org\/10.1016\/j.pmedr.2025.103161","relation":{},"ISSN":["2211-3355"],"issn-type":[{"value":"2211-3355","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-related behavioral changes following the use of psychedelics in naturalistic settings","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmedr.2025.103161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103161"}}